期刊文献+

中药固体化纳米混悬给药系统的研究进展与思考 被引量:15

Research progress and thinking on solidification nanosuspensions drug delivery system of Chinese materia medica
原文传递
导出
摘要 纳米混悬给药系统为改善难溶性中药成分的溶解度和生物利用度提供了一条新的途径。研究具有再分散性能的固体化纳米混悬给药系统,是实现纳米混悬系统稳定化的理想选择,然而,固体化再分散后是否仍呈纳米状态,能否保持良好的再分散性,仍然是亟待解决的关键科学问题。主要综述了中药纳米混悬系统固体化的研究现状,并分析了纳米混悬系统固体化及其再分散稳定性的研究策略,以期"抛砖引玉",进一步促进中药纳米混悬给药系统制剂理论的完善与发展。 Nanosuspensions(NS) drug delivery system is used as a novel approcah to improve the solubility and bioavailability of poorly soluble ingredients in Chinese materia medica(CMM).Studying on solid redispersibility nanosuspension drug delivery system is the main choice for stabilization of nanosuspension system.However,whether solid is still in nano state after redispersing or can keep good redispersibility is an urgent scientific point.This paper reviews the research status of nanosuspensions system solidification and analyzes the research strategy of nanosuspensions system solidification and redispersion stability in order to "initiate" further investigations and studies to promote and develop the theory of CMM nanosuspension drug delivery system.
出处 《中草药》 CAS CSCD 北大核心 2012年第4期625-629,共5页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金资助项目(81102821)
关键词 纳米混悬给药系统 固体化 再分散性 中药 纳米技术 nanosuspensions drug delivery system solidification redispersibility Chinese materia medica(CMM) nanotechnology
  • 相关文献

参考文献26

  • 1Lipinski C A. Drug-like properties and the causes of poor solubility and poor permeability[J].Journal of Pharmacological and Toxicological Methods,2000,(01):235-249.
  • 2张洪兵,朱雪瑜,张铁军.纳米技术应用于中药制剂的研究进展[J].现代药物与临床,2011,26(3):208-211. 被引量:10
  • 3周闻舞,顾海铮.壳聚糖微/纳米粒在定向给药系统中的应用研究[J].药物评价研究,2010,33(4):290-295. 被引量:31
  • 4Müller R H,Heinemann S. Emulsions for intravenous administration.Ⅰ.Emulsions for nutrition and drug delivery[J].PHARMAZEUTISCHE INDUSTRIE,1993,(09):853-856.
  • 5Collins-Golda L C,Lyonsa R T,Bartholow L C. Parenteral emulsions for drug delivery[J].Advanced Drug Delivery Reviews,1990,(03):189-208.
  • 6Rabinow B E. Nanosuspensions in drug delivery[J].Nature Reviews Drug Discovery,2004,(09):785-796.
  • 7Kobierski S,Ofori-Kwakye K,Müller R H. Resveratrol nanosuspensions for dermal application-production,characterisation and physical stability[J].Die Pharmazie,2008,(11):741-747.
  • 8Indrajit G,Sonali B,Radha V. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth[J].International Journal of Pharmaceutics,2011,(01):260-268.
  • 9Jacobs C,Kayser O,Müller R H. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide[J].International Journal of Pharmaceutics,2000,(02):161-164.
  • 10Kocbek P,Baumgartner P,Kristl J. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs[J].International Journal of Pharmaceutics,2006,(1/2):179-186.

二级参考文献79

共引文献96

同被引文献204

引证文献15

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部